Finn Olav Levy group

Finn Olav Levy Group

Group strategy

Achieve a thorough understanding of receptor-mediated neurohumoral signalling and signal transduction in normal and failing hearts, changes occuring in heart failure and translation of this understanding into novel pharmacological treatment of heart failure.

Understand the signalling mechanisms of and the importance of splice variant diversity among 5-HT4 and 5-HT7 serotonin receptors.

Head of group

Levy, Finn Olav


Finn Olav Levy

Professor, MD, PhD

Group members

Webmaster Vidar, IEMF